NSE filing, NSE: BIOCON. Summary written from the filing by ALFA Finder's alert engine.
Biocon Ltd: key numbers
- Share price
- ₹351.80
- Market cap
- ₹57,333 Cr
- Revenue (annual)
- ₹16,927 Cr
- Net profit (annual)
- ₹385.6 Cr
- P/E (TTM)
- 115.8×Sector 45.9×
- Promoter holding
- 44.68%+0.00% QoQ
- FII holding
- 8.64%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Biocon Ltd
All →Biocon Board Meeting Date
Biocon schedules a November 4, 2026 board meeting for Q2 FY27 unaudited results, plus an earnings call. Trading window stays closed until November 6, 2026.
Biocon Business Update
Biocon signed a licence agreement with Janssen to commercialise biosimilar Yesintek in nine more markets, including Australia, Brazil and China. No deal value is disclosed.
Biocon Other Announcement
Biocon Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026. The filing details the distribution of equity shares among various stakeholder categories.
Biocon Partnership
Biocon entered a global patent settlement and license agreement with Genentech, securing early launch dates for its biosimilar Pebrilzo® (bPertuzumab) across key global markets.
- From
- Genentech
Biocon Legal & Regulatory
Biocon received a GST demand order for ₹3.21 Crore, including tax, interest, and penalty. The company intends to file a rectification application or appeal.
- Value
- ₹3.21 Cr
Biocon Employee Stock Options
Biocon Limited announced the grant of 94,60,232 stock options to eligible employees under its Biocon Unity Long Term Incentive Plan 2026.
Other management change announcements
All →Premier Explosives Management Change
Premier Explosives disclosed that Lt. Gen. Peruvemba Ramachandran Kumar ceases as Independent Director on completing his second five-year term, effective close of business on 1 November 2026. The company placed on record its appreciation for his contributions.
Axis Bank Management Change
Axis Bank disclosed that Independent Director Girish Paranjpe ceased to be a director on completion of his tenure, effective close of business on 1 November 2026. No monetary value is involved in this change.
KSB Management Change
KSB Limited announced Uday Joshi's designation as General Manager – Project Contract Management from November 1, 2026. It also disclosed the superannuation cessation of Mukesh Pattewar as Head – Project and Contract Management, effective December 31, 2026.
Oil And Natural Gas Corporation Management Change
ONGC disclosed that Executive Director Sanjay Kumar Singh retires on superannuation effective 1 November 2026. Deepali Masirkar joins as Executive Director on deputation from 28 October 2026.
Kingfa Science & Technology (India) Management Change
Kingfa disclosed that Nilima Ramrao Shinde ceased as Non-Executive Independent Director on tenure completion, effective 31 October 2026. No monetary value is involved.
Ashika Global Securities Management Change
Ashika Global Securities disclosed the re-appointment of Amit Jain as Whole-Time Director of unlisted material subsidiary Ashika Stock Services for three years from 1 November 2026. The filing reports a senior management reappointment with no monetary value.
- Execution
- 3 years, 01 November 2026 to 31 October 2029